Management of the heartbeating brain-dead organ donor
نویسندگان
چکیده
منابع مشابه
Management of the heartbeating brain-dead organ donor.
The main factor limiting organ donation is the availability of suitable donors and organs. Currently, most transplants follow multiple organ retrieval from heartbeating brain-dead organ donors. However, brain death is often associated with marked physiological instability, which, if not managed, can lead to deterioration in organ function before retrieval. In some cases, this prevents successfu...
متن کاملThe dead donor rule and organ transplantation.
674 S ince its inception, organ trans-plantation has been guided by the overarching ethical requirement known as the dead donor rule, which simply states that patients must be declared dead before the removal of any vital organs for transplantation. Before the development of modern critical care, the diagnosis of death was relatively straightforward: patients were dead when they were cold, blue...
متن کاملChallenges in facing organ donation request of the family of brain-dead patients: a qualitative analysis
Background: The sudden nature of confrontation with brain death complicates organ donation request and makes the understanding difficult for the family. Understanding the experience of these families with inductive approach provides a better understanding of their problems and explains the approaches to help families in this difficult and complex situation. Aim: To discover mental concerns and...
متن کاملRole of brain death and the dead-donor rule in the ethics of organ transplantation.
The "dead-donor rule" requires patients to be declared dead before the removal of life-sustaining organs for transplantation. The concept of brain death was developed, in part, to allow patients with devastating neurologic injury to be declared dead before the occurrence of cardiopulmonary arrest. Brain death is essential to current practices of organ retrieval because it legitimates organ remo...
متن کاملThe dead-donor rule and the future of organ donation.
1287 cular risks of rosiglitazone led to a major change in FDA policy regarding the approval of all new diabetes drugs. From a cardiovascular perspective, rosiglitazone, saxagliptin, and alogliptin appear to be relatively safe. It is disappointing, however, that neither intensive glycemic control nor the use of specific diabetes medications is associated with any suggestion of cardiovascular be...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Anaesthesia
سال: 2012
ISSN: 0007-0912
DOI: 10.1093/bja/aer351